Overview of Blood Coagulation

Area of Science:

• Vascular Biology
• Hemostasis and Thrombosis

Background:

• The endothelium acts as a primary anti-thrombotic barrier.
• It produces vasodilators like nitric oxide and prostacyclin, and clotting inhibitors such as thrombomodulin and tissue factor pathway inhibitor (TFPI).

Purpose of the Study:

• To detail the endothelial mechanisms involved in preventing and promoting blood clot formation.
• To elucidate the interplay between endothelial integrity, platelet activation, and coagulation cascades.

Main Methods:

• Review of established physiological and biochemical pathways governing hemostasis.
• Analysis of endothelial cell responses to injury, including vasoconstriction and platelet adhesion.
• Examination of coagulation factor activation and inhibition, and fibrinolysis regulation.

Main Results:

• Endothelial breach initiates vasoconstriction and platelet adhesion via von Willebrand factor.
• Platelet activation and microparticle formation create a pro-thrombotic surface, amplifying thrombin generation.
• Thrombin activates thrombin activatable fibrinolysis inhibitor (TAFI), inhibiting clot breakdown.
• Multiple inhibitory mechanisms, including TFPI, activated protein C, and thrombin-binding proteins, limit clot propagation.
• Fibrinolysis is facilitated by plasminogen activators like tissue plasminogen activator and urokinase.

Conclusions:

• The endothelium plays a dual role in hemostasis, preventing thrombosis under normal conditions and promoting clot formation upon injury.
• A complex network of activators and inhibitors regulates coagulation and fibrinolysis to maintain vascular integrity.